Somatic WT1 mutations occur in approximately 6–15% of AML patients at diagnosis (reviewed by [32]) and are more frequent at a younger age and in cytogenetically normal AML (CN-AML) patients [31,32], which account for 40–50% of AML patients [33,34]. This evidence concerns the gene WT1 and acute myeloid leukemia.